Br[CH2:2][C:3]([C:5]1[CH:14]=[C:13]2[C:8]([CH2:9][CH2:10][N:11]([CH3:15])[CH2:12]2)=[CH:7][CH:6]=1)=[O:4].[Cl:16][C:17]1[CH:25]=[C:24]2[C:20]([C:21]([CH2:38][C:39]([O:41][CH3:42])=[O:40])=C(C(C3N=CC4CCCCC=4C=3)=O)[NH:23]2)=[CH:19][CH:18]=1>>[Cl:16][C:17]1[CH:25]=[C:24]2[C:20]([C:21]([CH2:38][C:39]([O:41][CH3:42])=[O:40])=[C:2]([C:3]([C:5]3[CH:14]=[C:13]4[C:8]([CH2:9][CH2:10][N:11]([CH3:15])[CH2:12]4)=[CH:7][CH:6]=3)=[O:4])[NH:23]2)=[CH:19][CH:18]=1The title compound was prepared according to the procedure described in step 2 of Example 1 from 7-bromoacetyl-2-methyl-1,2,3,4-tetrahydroisoquinoline* and methyl trans-4-chloro-2-[(phenylsulfonyl)amino]cinnamate (Example 1, step 1).